M/A treatment of glioblastoma mice also resulted in a slight but significant decrease in tNOX expression in the brain tissues (Figure 2I), and a strong decrease (~3-fold) in TGF-β1 release in the blood (Figure 2J). The gene discussed is TGFB1; the disease is glioblastoma.